SAKRX LLC NPI 1720553761

NPI Details

SAKRX, LLC is a durable medical equipment medical supplies in Omaha, NE. The provider is a supplier of medical equipment such as respirators, wheelchairs, home dialysis systems, or monitoring systems, that are prescribed by a physician for a patient's use in the home and that are usable for an extended period of time. SAKRX, LLC NPI is 1720553761. The provider is registered as an organization entity type.
The provider .

The provider's business location address is:

12741 Q ST
OMAHA, NE
ZIP 68137-211
Phone: (402) 895-3102

The provider's authorized official is Peter E Jensen .
The authorized official title is Cfo and has the following contact phone number (402) 973-1915.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Administration of influenza virus vaccine (HCPCS:G0008)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Covid-19 vaccine administration inside a patient's home; reported only once per individual home per date of service when only covid-19 vaccine administration is performed at the patient's home (HCPCS:M0201)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)

The enumeration date for this NPI number is 10/5/2018 and was last updated on 4/1/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: